Search results for: 'c-Abl'
-
B5832 Altiratinib1 CitationTarget: FLT3|VEGFR|Trk Receptors|c-MET|Tie-2Summary: c-MET/TIE-2/VEGFR inhibitor
-
A8550 Telatinib (BAY 57-9352)Target: VEGFR|PDGFR|c-KitSummary: VEGFR-2/-3,PDGFR-β and c-Kit inhibitor
-
A8525 Sotrastaurin (AEB071)Target: PKCSummary: PKC inhibitor
-
A3022 Pazopanib (GW-786034)Target: CSF-1R|VEGFR|PDGFR|c-Kit|FGFRSummary: VEGFR/PDGFR/FGFR inhibitor
-
A4137 AZD1480Target: JAKSummary: JAK2 inhibitor,ATP-competitive and novel
-
A8253 PD 173074Target: VEGFR|FGFRSummary: FGFR inhibitor
-
A8313 RAF265Target: Raf|VEGFRSummary: Multiple intracellular kinases inhibitor
-
A2678 SU112742 CitationTarget: METSummary: C-Met inhibitor,potent and selective
-
B2172 PP121Target: mTOR|Eph Receptors|VEGFR|PDGFR|Bcr-Abl|Src|DNA-PK|P110|HckSummary: Dual inhibitor of tyrosine and phosphoinositide kinases
-
A4105 M3441 CitationTarget: Histone Deacetylases (HDACs)Summary: HDAC inhibitor,potent and cell-permeable